Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Semin Nephrol. 2022 Jan;42(1):63–75. doi: 10.1016/j.semnephrol.2022.01.003

Table 2.

Recommended waiting times between cancer remission and kidney transplantation

Cancer Type Stage Waiting Time
Breast Early At least 2 years
Advanced At least 5 years
Colorectal Dukes A/B At least 2 years
Dukes C 2-5 years
Dukes D At least 5 years
Bladder Invasive At least 2 years
Kidney Incidentaloma (<3 cm) No waiting time
Early At least 2 years
Large and invasive At least 5 years
Uterine Localized At least 2 years
Invasive At least 5 years
Cervical Localized At least 2 years
Invasive At least 5 years
Lung Localized 2-5 years
Testicular Localized At least 2 years
Invasive 2-5 years
Melanoma Localized At least 5 years
Invasive Contraindicated
Prostate Gleason ≤6 No waiting time
Gleason 7 At least 2 years
Gleason 8-10 At least 5 years
Thyroid (Papillary/Follicular/Medullary) Stage 1 No waiting time
Stage 2 At least 2 years
Stage 3 At least 5 years
Stage 4 Contraindicated
Anaplastic Contraindicated
Hodgkin Lymphoma Localized At least 2 years
Regional 3-5 years
Distant At least 5 years
Non-Hodgkin Lymphoma Localized At least 2 years
Regional 3-5 years
Distant At least 5 years
Post-transplant lymphoproliferative disease Nodal At least 2 years
Extra-nodal and cerebral At least 5 years

Adapted from the KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.